503B Compounding Pharmacy is an FDA-registered outsourcing facility operating under Section 503B of the Federal Food, Drug, and Cosmetic Act, providing large-scale, sterile compounded medications to healthcare systems across the United States. The pharmacy is built to serve hospitals, surgery centers, clinics, and licensed healthcare providers that require consistent, compliant, and scalable access to compounded pharmaceuticals without patient-specific prescriptions. Operating from its facility at 2160 W State Road 434, Longwood, FL 32779, 503B Compounding Pharmacy follows current Good Manufacturing Practice (cGMP) standards and is subject to routine FDA inspection. This places it in a fundamentally different category than traditional 503A pharmacies. The focus is not retail compounding or one-off prescriptions. The focus is controlled production, batch consistency, sterility assurance, and regulatory discipline. The facility specializes in sterile injectable and non-sterile compounded medications designed to address drug shortages, support procedural efficiency, and improve supply chain reliability for healthcare providers. All production is performed in ISO-classified cleanroom environments using validated processes, documented quality systems, and lot-level traceability. Each batch undergoes appropriate sterility, endotoxin, and potency testing based on risk level and formulation requirements. 503B Compounding Pharmacy prioritizes transparency and compliance over speed or marketing claims. Products are compounded using USP-grade ingredients sourced from vetted suppliers, with full documentation available for healthcare partners. Beyond production, the pharmacy supports client institutions with regulatory documentation, recall readiness, adverse event reporting protocols, and consistent supply planning. The company exists to solve real operational problems for healthcare organizations. Drug shortages, inconsistent manufacturers, and unreliable distributors create risk for patient care. A properly run 503B facility reduces that risk by acting as a compliant, predictable manufacturing partner rather than a reactive supplier.
503B Compounding Pharmacy at 2160 W State Road 434, Longwood, FL 32779
503B Compounding Pharmacy is an FDA-registered outsourcing facility operating under Section 503B of the Federal Food, Drug, and Cosmetic Act. Our facility at 2160 W State Road 434, Longwood, FL 32779 is dedicated to the large-scale compounding of sterile and non-sterile medications. As a 503B outsourcing facility, we adhere to the highest standards of quality and safety, including current Good Manufacturing Practices (cGMP), which are more rigorous than the standards applied to traditional compounding pharmacies. This ensures that every preparation leaving our facility is of consistent quality, strength, and purity.
The primary distinction of a 503B outsourcing facility is our ability to compound medications in advance of or without receiving a patient-specific prescription. This allows us to provide healthcare facilities and providers in Longwood with essential medications that may be in short supply or discontinued by major manufacturers. Our operations are subject to regular FDA inspections, providing an additional layer of oversight and assurance for the medical community we serve at our location on State Road 434.
While we do not dispense medication directly to individual patients based on a walk-in model, our services are fundamental to the local healthcare infrastructure. We supply compounded medications to physicians, clinics, hospitals, and healthcare providers for their office use and for administration to patients within their care. This vital service helps ensure that medical professionals at facilities near 2160 W State Road 434 have access to the critical medications they need to treat their patients effectively.
Our commitment is to support the health and well-being of the Longwood community by being a reliable and trusted source of high-quality compounded pharmaceuticals. We focus on precision, sterility, and compliance in every batch we produce. For more information on how our 503B outsourcing facility can serve your practice, or to inquire about our available preparations, please contact us.
Website: | Phone: (407)993-1381
Frequently Asked Questions for 503B Compounding Pharmacy
1. What does it mean that you are a 503B outsourcing facility?
It means our pharmacy at 2160 W State Road 434, Longwood, FL 32779 is registered with the FDA as an outsourcing facility under Section 503B of the FD&C Act. This registration requires us to comply with stringent current Good Manufacturing Practices (cGMP) and undergo regular FDA inspections, ensuring a higher level of oversight for the quality, safety, and sterility of the medications we compound.
2. Can I, as an individual, walk into your location to get a prescription filled?
No, 503B Compounding Pharmacy does not typically dispense medications directly to individual patients from our facility at 2160 W State Road 434. We operate as a bulk compounding facility, supplying medications in larger quantities to healthcare providers, hospitals, and clinics for office use or administration to their patients.
3. What types of medications do you compound at your Longwood facility?
As a 503B outsourcing facility, we compound a wide range of sterile and non-sterile medications. This often includes preparations that are on drug shortage lists or have been discontinued by commercial manufacturers. Healthcare providers serving the Longwood area can contact us at (407)993-1381 to inquire about our current list of available compounded preparations.
4. How does a healthcare provider at a local clinic order from your pharmacy?
Healthcare providers and facilities can place orders directly with our facility at 2160 W State Road 434, Longwood, FL 32779. They can initiate the process by calling our main line at (407)993-1381 to establish an account and discuss their specific medication needs and ordering protocols.
5. Why would a healthcare provider choose a 503B outsourcing facility over a traditional compounding pharmacy?
Healthcare providers choose a 503B outsourcing facility like ours for the added assurance of FDA oversight and cGMP compliance. This is particularly important for sterile injectables and medications used for vulnerable patients. It provides a level of quality control and consistency that is critical for office-use medications administered at their practice locations.